Loss of G0/G1 switch gene 2 (G0S2) promotes disease progression and drug resistance in chronic myeloid leukaemia (CML) by disrupting glycerophospholipid metabolism.

Published in:

Clinical & Translational Medicine, 2022, v. 12, n. 12, p. 1, doi. 10.1002/ctm2.1146

By:

• Gonzalez, Mayra A.;
• Olivas, Idaly M.;
• Bencomo‐Alvarez, Alfonso E.;
• Rubio, Andres J.;
• Barreto‐Vargas, Christian;
• Lopez, Jose L.;
• Dang, Sara K.;
• Solecki, Jonathan P.;
• McCall, Emily;
• Astudillo, Gonzalo;
• Velazquez, Vanessa V.;
• Schenkel, Katherine;
• Reffell, Kelaiah;
• Perkins, Mariah;
• Nguyen, Nhu;
• Apaflo, Jehu N.;
• Alvidrez, Efren;
• Young, James E.;
• Lara, Joshua J.;
• Yan, Dongqing

Publication type:

Article